Fibrinogen Concentrates Market Size to Hit USD 6.89 Bn by 2030

 According to Nova one advisor, the global Fibrinogen Concentrates market size is expected to hit around USD 6.89 billion by 2030 from valued at USD 2.98 billion in 2021 and growing at a CAGR of 8.1% from 2022 to 2030.

Request Free Sample of This Report@ https://www.novaoneadvisor.com/report/sample/7133

Fibrinogen Concentrates Market: Overview

• Fibrinogen is a soluble protein, also known as coagulation factor I in the plasma that is broken down to fibrin by the enzyme thrombin to form clots
• Human fibrinogen concentrates have been used for substitution therapy in cases of hypofibrinogenemia, dysfibrinogenemia, and afibrinogenemia. Commercially available human fibrinogen concentrate is virus-inactivated. Hence, it plays a critical role in hemostasis, especially in bleeding patients with an acquired fibrinogen deficiency.
• Rise in demand for fibrinogen among physicians as blood clot formation agents, increase in the number of cases of bleeding disorders, and surge in the availability of fibrinogen products are key factors projected to drive the global fibrinogen concentrates market during the forecast period. Furthermore, increase in investment in research & development (R&D) and large number of products under pipeline offer significant opportunities in the market.
• In November 2018, Octapharma received marketing authorization from the Swiss Agency for therapeutic products for fibryga, a lyophilized fibrinogen concentrate for intravenous infusion indicated for the treatment of congenital and acquired fibrinogen deficiencies

Report Scope of the Fibrinogen Concentrates Market

Ask here for more customization study@ https://www.novaoneadvisor.com/report/customization/7133

Generation of Strong Data Boosts Application of Fibrinogen Concentrates for TIC

Since trauma is the leading cause of mortality with major bleeding and trauma-induced coagulopathy (TIC), fibrinogen concentrate is being publicized as the first line of treatment for TIC. Contributing factors such as initiatives to improve TIC management, generation of stronger data, and improved medical education are of paramount importance to increase better patient outcomes. Simplified practice guidance and improved access to viscoelectic testing are forming critical factors for growth of the fibrinogen concentrates market.

TIC requires different treatment strategies, which include tranexamic acid (TXA), human fibrinogen concentrate, and prothrombin complex concentrates (PCCs), among others. Manufacturers in the fibrinogen concentrates market are gaining awareness about such patient demands and requirements from healthcare systems.

Education, Network Building Significant for Improvement in Blood Products

Canadian Blood Services - a provider of lifesaving products and services in transfusion and transplantation for patients is gaining recognition for continuously improving blood products and their utilization, which results in improvement of patient quality of life. Stakeholders in the fibrinogen concentrates market are taking cues from such developments to build their network of scientists, medical experts, collaborators, and research partners to improve blood products.

Guided clinical practices are supporting national studies, which suggest that fibrinogen concentrate is equivalent to cryoprecipitate in controlled post-operative bleeding. Such insights are impacting the way cardiac patients can be treated in various healthcare facilities. Stakeholders are realizing the importance of R&D, training, education, and engagement activities that play a key role in improving blood products. On the other hand, fibrinogen concentrate is being preferred over fresh frozen plasma (FFP), since the former delivers a standardized and higher concentration of coagulation proteins.

Market Segmentation: Fibrinogen Concentrates Market

• In terms of application, the global fibrinogen concentrates market has been classified into general coagulation management, surgery, and others
• Based on end user, the global fibrinogen concentrates market has been divided into hospitals, ASCs, and others
• Each of the segments has been analyzed in detail for trends, recent trends & developments, drivers, restraints, opportunities, and useful insights. The fibrinogen concentrates market report provides current and future revenue (US$ Mn) for each of these segments for the period from 2017 to 2030, considering 2021 as the base year. The compound annual growth rate (% CAGR) has been provided for each segment and market from 2021 to 2030, along with market size estimations.

Regional Overview: Fibrinogen Concentrates Market

• In terms of region, the global fibrinogen concentrates market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been divided into major countries and sub-regions.
• Europe held a significant share of the global fibrinogen concentrates market in 2021, followed by North America. Europe is likely to retain market share during the forecast period. High awareness about the availability of different brands of fibrinogen concentrate products and early introduction of fibrinogen concentrates drive the market in the region.
• Asia Pacific is likely to gain market share during the forecast period. Product launches, acquisitions, distribution agreements, alliances, and geographical expansion by players, especially in China and Japan, are projected to propel the fibrinogen concentrates market in the region.
• Current and future market sizes in terms of value (US$ Mn) of these regional markets and major countries have been provided in the fibrinogen concentrates market report for the period from 2017 to 2030, along with their CAGRs for the period from 2020 to 2030
• The study also offers a list of recommendations, highlights, and useful insights of the market, which are likely to help new companies willing to enter the fibrinogen concentrates market and existing companies to increase market share and in the decision-making process

Some of the prominent players in the Fibrinogen Concentrates Market include:

• CSL Behring
• Baxter
• Johnson & Johnson (Ethicon)
• LFB Group
• ProFibrix BV (The Medicines Company)
• Shanghai RAAS
• Jiangxi Boya Bio-Pharmaceutical
• Hualan Biological Engineering
• Harbin Pacific Biopharmaceutical
• Greencross

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Fibrinogen Concentrates market

By Type

• Human
• Animal

Application

• General Coagulation Management
• Surgery
• Others

End User

• Hospitals
• ASCs
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Full Report is Ready | For Purchase Inquiry@ https://www.novaoneadvisor.com/report/checkout/7133

You can place an order or ask any questions, please feel free to sales@novaoneadvisor.com| +1 9197 992 333

Blog: https://www.novaoneadvisor.com/

Blog: https://www.visionresearchreports.com/

Blog: https://qyresearchmedical.com/